The Lilac2 trial which was by invitation now no longer recruits, the patients initially expected were 153 but 78 were effective:
https://clinicaltrials.gov/ct2/history/NCT04776746?A=21&B=22&C=merged#StudyPageTop
Acadia's 2 trials on irritability associated with autism spectrum disorder are advancing fast and recruiting also in Europe:
https://clinicaltrials.gov/ct2/show/NCT05523895?term=Pimavanserin&draw=2&rank=5
https://clinicaltrials.gov/ct2/show/NCT05555615?term=Pimavanserin&draw=2&rank=1
Happy Easter everyone
Acadia, page-244
-
- There are more pages in this discussion • 434 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |